Association between ibrutinib treatment and hypertension

Retrospective study of patients with B cell malignancies (n=144) found both systolic and diastolic BP increased over time in those treated with ibrutinib, whereas conventional chemoimmunotherapy was not associated with such changes (36.6% v 7.9% had increase >10 mmHg at 1 month).

Source:

Heart